Halozyme Therapeutics Inc.
P/E (Price-to-Earnings)
Price
EPS
P/E (Price-to-Earnings)
| Fiscal Year | P/E (Price-to-Earnings) | EPS | Price |
|---|---|---|---|
| Sep 2018 | 0.02x | $849.46 | $14.63 |
| Dec 2020 | 47.46x | $0.90 | $42.71 |
| Dec 2021 | 14.68x | $2.74 | $40.21 |
| Dec 2022 | 39.51x | $1.44 | $56.90 |
P/E (Price-to-Earnings)
Price
EPS
P/E (Price-to-Earnings)
| Fiscal Year | P/E (Price-to-Earnings) | EPS | Price |
|---|---|---|---|
| Sep 2018 | 0.02x | $849.46 | $14.63 |
| Dec 2020 | 47.46x | $0.90 | $42.71 |
| Dec 2021 | 14.68x | $2.74 | $40.21 |
| Dec 2022 | 39.51x | $1.44 | $56.90 |